Fecal Microbiota Transplantation Could Be First-Line Therapy for C. Difficile
Physician's Weekly
JUNE 25, 2025
from Oslo University Hospital in Norway, and colleagues examined the efficacy and safety of FMT in primary CDI in a randomized, open-label, noninferiority trial. The researchers found that clinical cure and no disease recurrence within 60 days without additional treatment was observed in 66.7 Frederik Emil Juul, M.D., Additional C.
Let's personalize your content